Ticker Scorecard - TTOO Basics Company: T2 Biosystems, Inc. IPO Date: August 7, 2014 Sector: Healthcare Industry: Medical Diagnostics and Research Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 4.36% Avg Daily Range (30 D): $0.02 | 14.09% Avg Daily Range (90 D): $0.03 | 8.19% Institutional Daily Volume Avg Daily Volume: .1M Avg Daily Volume (30 D): 1.93M Avg Daily Volume (90 D): 1.16M Trade Size Avg Trade Size (Sh.): 15 Avg Trade Size (Sh.) (30 D): 977 Avg Trade Size (Sh.) (90 D): 586 Institutional Trades Total Inst.Trades: 101 Avg Inst. Trade: $1.66M Avg Inst. Trade (30 D): $.51M Avg Inst. Trade (90 D): $.51M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.16M Avg Closing Trade (30 D): $.51M Avg Closing Trade (90 D): $.51M Avg Closing Volume: 21.44K     News Jul 22, 2024 @ 8:39 PM T2 Biosystems to Report Second Quarter 2024 Financ... Source: N/A May 22, 2024 @ 1:00 PM T2 Biosystems Regains Compliance with Nasdaq Conti... Source: T2 Biosystems, Inc. May 17, 2024 @ 8:05 PM T2 Biosystems Announces Closing of $8 Million Priv... Source: T2 Biosystems, Inc. May 14, 2024 @ 9:00 PM T2 Biosystems Announces CRG’s Conversion fr... Source: T2 Biosystems, Inc. May 6, 2024 @ 8:34 PM T2 Biosystems Announces First Quarter 2024 Financi... Source: T2 Biosystems, Inc. Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.57 $-.64 $-2.66 Diluted EPS $-.57 $-.64 $-2.66 Revenue $ 1.99M $ 1.95M $ 2.06M Gross Profit $ $ $ Net Income / Loss $ -10.12M $ -8.96M $ -13.53M Operating Income / Loss $ -10.16M $ -9.58M $ -12.6M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Oct 13, 2023:   100:1 Oct 13, 2022:   50:1